Jan 10 (Reuters) - Ultragenyx Pharmaceutical Inc:
* CAPITAL INTERNATIONAL INVESTORS REPORTS 10.3 PERCENT PASSIVE STAKE IN ULTRAGENYX PHARMACEUTICAL INC AS OF DECEMBER 29, 2017 - SEC FILING‍​ Source text for Eikon: ( bit.ly/2D1HymY ) Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.